background
human
metapneumoviru
hmpv
shown
caus
respiratori
infect
account
approxim
diseas
contribut
develop
asthma
human
hmpv
worldwid
distribut
infect
rate
approach
immunocompromis
patient
particularli
risk
viral
exposur
antihmpv
vaccin
avail
diagnosi
primarili
base
inhous
molecular
serolog
test
part
due
limit
avail
recombin
hmpv
antigen
object
gener
panel
hmpvderiv
recombin
antigen
develop
standardis
elisa
system
hmpv
igg
detect
explor
natur
b
cell
memori
hmpv
underpin
futur
vaccin
studi
studi
design
hmpv
viral
rna
isol
clinic
specimen
rtpcr
conduct
hmpv
p
gene
clone
express
escherichia
coli
hmpv
n
gene
clone
express
insect
cell
use
baculoviru
express
system
purifi
recombin
antigen
subsequ
employ
hmpvspecif
elisa
result
highlevel
express
purif
hmpv
matrix
mgg
cell
phosphoprotein
p
mgg
cell
achiev
e
coli
express
system
recombin
hmpv
n
success
express
purifi
baculoviru
express
system
overal
hmpv
igg
seropreval
observ
n
use
hmpv
nand
pelisa
respect
antigen
prove
diagnost
use
specimen
test
exhibit
antim
protein
reactiv
high
correl
observ
antim
n
igg
reactiv
r
signific
correl
also
evid
antin
p
igg
reactiv
r
lowest
correl
evid
antim
p
igg
reactiv
r
final
first
demonstr
hmpvspecif
b
cell
memori
rang
spot
form
cell
sfc
million
cell
achiev
p
antigen
individu
test
conclus
work
describ
robust
diagnost
system
hmpv
new
insight
antigenspecif
b
cell
memori
hmpv
viral
respiratori
diseas
major
health
problem
affect
peopl
age
exert
great
econom
impact
health
care
system
virus
often
associ
respiratori
tract
ill
includ
influenza
viru
parainfluenza
viru
respiratori
syncyti
viru
rsv
adenoviru
rhinoviru
coronaviru
van
den
hoogen
colleagu
first
report
discoveri
new
respiratori
viru
human
metapneumoviru
hmpv
netherland
serolog
studi
reveal
virtual
children
expos
hmpv
age
year
similar
studi
seem
support
hypothesi
howev
case
studi
hmpv
infect
report
elderli
immunocompromis
individu
suggest
viru
strictli
limit
infect
infant
children
sinc
discoveri
occurr
hmpv
report
mani
countri
australia
canada
finland
unit
state
unit
kingdom
spain
ireland
israel
japan
thought
preval
worldwid
indic
common
ubiquit
human
pathogen
clinic
manifest
hmpv
includ
tachypnea
rhinorrhea
nasal
congest
cough
fever
hypoxia
pharyng
hyperinfl
peribronchi
cuf
wheez
bronchiol
pneumonia
respiratori
failur
earlier
recognit
viru
delay
difficult
detect
cell
see
front
matter
elsevi
bv
right
reserv
cultur
due
slow
growth
mild
cytopath
effect
therefor
await
develop
revers
transcriptasepcr
rtpcr
consider
effort
direct
toward
elucid
natur
cell
respons
hmpv
yet
natur
b
cell
memori
direct
hmpv
remain
unclear
memori
b
cell
make
signific
contribut
protect
immun
characteris
term
rapid
prolif
respons
accompani
cellular
differenti
upon
antigen
reexposur
produc
affinitymatur
antibodysecret
plasma
cell
ii
lower
activ
threshold
rel
b
cell
respons
cytokin
antigen
presenc
iii
absenc
spontan
ig
secret
evalu
b
cell
memori
may
consider
import
respect
investig
immunolog
memori
hmpv
prove
use
elucid
virusspecif
b
cell
mediat
immun
hmpv
gener
panel
hmpvderiv
recombin
antigen
develop
standardis
elisa
system
hmpv
igg
detect
explor
natur
b
cell
memori
hmpv
underpin
vaccin
studi
briefli
rna
isol
bronchoalveolarlavag
bal
year
old
femal
patient
hmpv
isol
genotyp
rtpcr
conduct
use
qiagen
one
step
rtpcr
kit
three
gene
hmpv
matrix
kb
hmpv
phosphoprotein
p
kb
hmpv
nucleoprotein
n
kb
amplifi
hmpv
p
gene
sequenc
amplifi
use
oligonucleotid
primer
select
region
mfor
gagaaggcctatg
gagtcctacctagtagac
mrev
gagactcgagtctggacttcagcac
pfor
gagaaggcctatgtcgttccctgaagga
prev
gagactcgag
cataattaactggtagatgtc
restrict
site
stui
xhoi
underlin
ensur
optim
direct
clone
pproex
tm
htb
express
vector
fig
hmpv
pcr
cycl
condit
c
min
follow
cycl
c
min
c
min
c
min
final
extens
step
c
min
perkinelm
warrington
cheshir
uk
model
thermal
cycler
hmpv
p
pcr
cycl
condit
ident
gene
except
anneal
temp
c
express
hmpv
protein
induc
addit
isopropyl
iptg
mm
final
control
lac
promot
fig
protein
highli
insolubl
present
cell
pellet
determin
sdspage
western
blot
analysi
use
monoclon
antibodi
reactiv
tag
present
recombin
protein
therefor
purifi
inclus
bodi
use
differenti
protein
extract
method
briefli
h
postinduct
cell
lyse
incub
lysozym
gml
sodium
deoxychol
wv
presenc
proteas
inhibitor
cocktail
cell
debri
remov
centrifug
g
min
inclus
bodi
wash
twice
mm
tri
mm
edta
contain
triton
ph
follow
third
mm
tri
urea
ph
wash
centrifug
perform
describ
final
protein
pellet
solubilis
addit
tri
mm
ph
contain
urea
mm
edta
mm
dithiothreitol
dtt
agit
min
room
temperatur
aliquot
purifi
hmpv
protein
store
c
recombin
hmpv
gml
serial
dialys
urea
buffer
mm
sodium
carbon
ph
express
hmpv
p
protein
induc
similar
protein
hmpv
p
protein
express
ntermin
tag
aid
protein
purif
fig
recombin
hmpv
p
protein
purifi
ninta
chromatographi
qiagen
west
sussex
uk
denatur
condit
necessari
design
primer
amplifi
region
molecular
clone
pbluebac
vector
oligonucleotid
primer
design
select
region
nfor
acaggatccgatgtctcttcaagggattcac
nrev
tatgaattcgcctcataatcattttgactg
pcr
product
digest
ligat
bamhiecori
site
restrict
site
underlin
pbluebac
vector
fig
hmpv
n
pcr
cycl
condit
c
min
follow
cycl
c
min
c
min
c
min
final
extens
step
c
min
recombin
hmpv
n
protein
purifi
whole
cell
suspens
cell
lyse
ml
lysi
buffer
mm
trishcl
urea
mm
nacl
ph
affin
chromatographi
denatur
condit
malditof
ms
carri
use
ettan
malditof
mass
spectromet
amersham
bioscienc
europ
gmbh
freiburg
germani
protein
sampl
excis
gel
process
describ
immunoblot
conduct
assess
igg
reactiv
denatur
form
hmpv
antigen
briefli
recombin
antigen
solubilis
sd
sampl
buffer
triscl
ph
sd
glycerol
dtt
wv
bromophenol
blue
heat
c
min
prior
layer
onto
sdspage
gel
sdspage
protein
electrophoret
transfer
nitrocellulos
ncp
schleicher
schuell
pore
size
protein
transfer
transblot
chamber
biorad
instrument
h
c
use
mm
trishcl
mm
glycin
vv
methanol
transfer
blot
block
incub
wv
nonfat
milk
powder
pb
h
room
temperatur
membran
cut
strip
incub
h
human
serum
antihi
monoclon
antibodi
use
posit
control
protein
presenc
immunostrip
wash
time
pb
contain
vv
pbst
incub
horseradish
peroxidas
hrp
conjug
antihuman
igg
dako
glostrup
denmark
h
follow
wash
step
time
pbst
immunoreact
strip
visual
use
diaminobenzidin
dab
human
sera
evalu
hmpv
igg
reactiv
recombin
hmpv
p
n
protein
elisa
assay
procedur
ident
corcoran
et
al
immunoassay
cutoff
determin
absorb
standard
deviat
greater
mean
absorb
obtain
panel
hmpv
igg
neg
sampl
neg
elisa
western
immunoblot
three
antigen
index
valu
iv
less
consid
seroneg
seroreact
group
follow
categori
seroneg
iv
weak
seroposit
iv
medium
seroposit
iv
high
seroposit
iv
briefli
peripher
blood
mononuclear
cell
pbmc
isol
quantifi
cultur
five
day
complet
rpmi
presenc
heatkil
staphylococcu
aureu
cell
sac
cowan
strain
sac
jointli
function
induc
generalis
antibodi
product
rest
memori
b
cell
hmpv
antigenspecif
memori
b
cell
wash
quantifi
spot
form
cell
sfc
elispot
techniqu
previous
describ
except
hmpv
antigen
use
b
cell
captur
express
foreign
protein
high
level
e
coli
often
result
format
inclus
bodi
insolubl
aggreg
express
protein
hmpv
recombin
protein
kda
highli
insolubl
present
cell
pellet
purifi
inclus
bodi
denatur
condit
use
differenti
extract
inclus
bodi
recov
bacteri
cell
lysat
centrifug
wash
triton
edta
remov
much
bacteri
protein
possibl
aggreg
protein
obtain
solubl
hmpv
protein
wash
inclus
bodi
dissolv
denatur
agent
releas
protein
refold
gradual
remov
denatur
reagent
dilut
dialysi
kda
hmpv
band
observ
follow
sdspage
fig
consist
predict
mr
protein
includ
tag
region
kda
tabl
purif
process
yield
mg
proteingram
cell
malditof
ms
analysi
recombin
hmpv
follow
trypsin
digest
confirm
ident
recombin
hmpv
genbank
access
wherebi
peptid
sequenc
coverag
observ
tabl
recombin
p
protein
observ
kda
follow
sdspage
analysi
fig
predict
mr
p
protein
plu
tag
region
kda
tabl
discrep
observ
predict
mr
may
attribut
fact
p
protein
low
isoelectr
point
ph
therefor
migrat
upon
sdspage
p
protein
purifi
affin
chromatographi
denatur
condit
rel
yield
purifi
p
protein
mgg
lyse
e
coli
fig
malditof
ms
analysi
recombin
hmpv
p
follow
trypsin
digest
confirm
ident
recombin
hmpv
p
genbank
access
sequenc
coverag
tabl
insect
cell
infect
recombin
baculovirusencod
hmpv
n
multipl
infect
moi
hmpv
n
recombin
protein
success
purifi
affin
chromatographi
denatur
condit
use
akta
chromatographi
system
amersham
purif
result
singl
major
protein
band
molecular
mass
kda
fig
purifi
protein
yield
cell
malditof
ms
analysi
purifi
hmpv
n
protein
confirm
ident
sequenc
coverag
tabl
defin
seroepidemiolog
hmpv
irish
popul
elisa
system
develop
use
three
recombin
hmpv
protein
detect
antigen
investig
seropreval
hmpv
total
human
sera
screen
elisa
sera
blood
donor
cohort
n
analys
duplic
elisa
e
coliexpress
hmpv
p
antigen
baculovirusexpress
hmpv
n
protein
establish
immunoassay
cutoff
hmpv
elisa
panel
igg
neg
sera
healthi
individu
identifi
elisa
western
immunoblot
fig
cutoff
establish
absorb
standard
deviat
greater
mean
absorb
obtain
panel
hmpv
igg
neg
sampl
neg
elisa
western
immunoblot
three
antigen
iv
less
consid
seroneg
total
number
seroposit
serum
specimen
weakli
seroposit
show
medium
seroreact
high
human
igg
reactiv
e
coliexpress
antigen
tabl
extens
seroreact
suggest
antigen
bind
igg
high
affin
occurr
specif
antihmpv
igg
common
recombin
p
elisa
overal
total
percentag
seroposit
seroneg
tabl
suggest
igg
human
sera
immunoreact
recombin
p
protein
fact
seroposit
specimen
weakli
seroposit
exhibit
medium
seroreact
high
igg
reactiv
tabl
percentag
human
igg
antibodi
reactiv
hmpvm
p
n
recombin
antigen
seroreact
group
follow
categori
seroneg
iv
weak
seroposit
iv
medium
seroposit
iv
high
seroposit
iv
categori
score
percentag
total
number
sera
screen
antigen
therefor
lower
seroreact
observ
via
elisa
within
sera
cohort
may
suggest
p
antigen
diagnost
use
hmpv
recombin
n
elisa
overal
total
percentag
seroposit
specimen
exhibit
reactiv
recombin
n
antigen
fig
data
demonstr
use
protein
result
higher
sensit
use
n
protein
subject
elisa
analysi
specimen
screen
weakli
seroposit
show
medium
seroreact
high
igg
reactiv
recombin
hmpv
n
antigen
tabl
show
sequenc
ident
hmpv
p
n
protein
use
studi
compar
exemplar
isol
repres
genotyp
use
hmpvspecif
b
cell
elispot
offer
possibl
confirm
past
exposur
infect
hmpv
seen
fig
individu
n
screen
hmpv
igg
seroposit
except
one
individu
index
valu
consid
seroposit
serum
seroneg
individu
neg
control
b
b
cell
memori
direct
hmpv
antigen
express
million
start
cell
mean
sd
triplic
well
elispot
micropl
coat
either
hmpv
protein
grey
hmpv
p
protein
dark
shade
gml
respect
c
reactiv
memori
b
cell
hmpv
hmpv
p
recombin
antigen
buffer
neg
control
nc
antigen
coat
plate
posit
control
pc
antihuman
igg
plate
detect
activ
memori
b
cell
secret
igg
scale
magnif
seroneg
elisa
seroneg
individu
four
seroposit
individu
appear
harbour
high
level
hmpvspecif
memori
b
cell
fig
five
seroposit
individu
exhibit
detect
tabl
percentag
protein
sequenc
ident
hmpv
antigen
isol
genotyp
compar
repres
isol
hmpv
genotyp
genbank
access
number
isol
follow
rang
sfcmillion
b
cell
hmpvspecif
b
cell
memori
hmpv
hmpv
p
antigen
fig
defin
seroepidemiolog
hmpv
irish
popul
develop
enzymelink
immunosorb
assay
elisa
base
express
hmpv
p
protein
e
coli
recombin
hmpv
n
produc
insect
cell
seroepidemiolog
survey
use
hmpv
recombin
antigenbas
elisa
system
employ
determin
preval
antibodi
specif
hmpv
protein
ireland
total
antibodi
reactiv
hmpv
p
n
antigen
correl
well
particular
signific
correl
seroreact
observ
n
elisa
system
r
tabl
correl
presenc
hmpv
antibodi
determin
p
elisa
lower
r
compar
correl
hmpv
n
elisa
signific
correl
also
observ
n
p
elisa
r
lack
correl
p
proteinbas
elisa
system
may
due
variabl
level
igg
recombin
antigen
within
select
donor
cohort
ishiguro
et
al
test
specif
antibodi
nucleocapsid
n
matrix
protein
sera
western
blot
use
recombin
n
protein
hmpv
express
e
coli
result
compar
immunofluoresc
assay
ifa
base
hmpvinfect
cell
express
whole
hmpv
proteom
result
indic
antibodi
n
protein
highli
specif
less
sensit
n
protein
protein
whole
protein
hmpv
detect
ifa
would
also
suggest
multihmpv
antigen
elisa
would
increas
sensit
detect
hmpv
antibodi
within
human
sera
howev
lower
detect
p
antigenspecif
igg
may
due
rel
low
percentag
sequenc
ident
hpmv
p
genotyp
genotyp
respect
hmpv
genotyp
protein
p
n
use
studi
exhibit
tabl
extens
valid
hmpv
elisa
system
describ
herein
wherebi
antigen
coat
microtitr
plate
optimis
gml
hmpv
p
n
respect
assay
reproduc
term
coeffici
variat
determin
respect
preclud
suboptim
assay
perform
reason
observ
differ
antibodi
detect
summari
recombin
p
n
protein
hmpv
antigen
respons
p
n
protein
differ
across
studi
popul
assay
base
multipl
antigen
provid
higher
sensit
assay
base
singl
antigen
defin
featur
acquir
immun
system
abil
gener
immunolog
memori
particular
pathogen
defenc
reinfect
recent
consider
effort
direct
toward
elucid
natur
cell
respons
hmpv
definit
cell
epitop
yet
natur
b
cell
memori
direct
hmpv
remain
unclear
individu
n
screen
hmpv
igg
seroposit
except
one
individu
seroneg
hmpv
specif
igg
fig
five
individu
exhibit
low
detect
rang
sfcmillion
b
cell
b
cell
memori
signific
correl
number
memori
b
cell
direct
hmpv
hmpv
p
antigen
r
howev
greatest
number
sfc
evid
two
individu
mean
sd
sfcmillion
cell
sfcmillion
cell
b
cell
memori
could
detect
absenc
sac
stimul
prior
elispot
analysi
unstimul
b
cell
control
fig
igg
reactiv
ten
specimen
hmpv
analys
elisa
compar
b
cell
elispot
data
statist
signific
posit
correl
observ
sfcmillion
cell
antibodi
reactiv
r
convers
correl
observ
elispot
result
igg
reactiv
hmpv
p
antigen
r
individu
exhibit
igg
specif
antibodi
respons
hmpv
p
antigen
confirm
previou
exposur
hmpv
also
result
b
cell
memori
mainli
individu
lack
correl
elispot
data
obtain
protein
obtain
elisa
data
unusu
detect
specif
serum
antibodi
wide
appli
method
investig
immun
diseas
like
hmpv
although
specif
correl
protect
hmpv
establish
yet
besid
antibodi
longterm
memori
b
cell
immun
might
play
import
role
protect
hmpv
individu
high
antibodi
level
low
number
memori
b
cell
found
strengthen
idea
longliv
plasma
cell
maintain
antibodi
level
memori
b
cell
distinct
popul
cell
memori
b
cell
secret
antibodi
prior
activ
upon
renew
antigen
stimul
memori
b
cell
may
rapidli
respond
prolifer
differenti
antibodi
secret
cell
ongo
circul
hmpv
among
irish
popul
caus
antigen
rechalleng
might
explain
low
correl
circul
hmpvspecif
memori
b
cell
antibodi
level
measur
studi
importantli
individu
hmpvspecif
memori
b
cell
well
low
hmpvspecif
antibodi
level
detect
might
result
higher
suscept
infect
hmpv
conclus
work
provid
multipl
new
detect
system
establish
seropreval
hmpv
igg
irish
popul
also
report
first
demonstr
hmpvspecif
b
cell
memori
hmpv
p
antigen
further
knowledg
antigenspecif
b
cell
memori
hmpv
viral
protein
determin
antigenspecif
b
cell
memori
statu
may
enhanc
serolog
molecular
analys
persist
hmpv
infect
studi
warrant
elucid
natur
differenti
seroreact
viral
antigen
